ISSN: 0004-1963 eISSN: 2217-8767 Journal category: M51 Distinguished National Journal
Saliva as an alternative biological fluid for therapeutic drug monitoring of mycophenolic acid in renal transplant recipients
Scindeks Assistant SCIndeks Assistant: Journal Management System
PDF

How to Cite

1.
Kundalić A, Stefanović N, Živanović S, Veličković-Radovanović R, Catić-Djordjević A. Saliva as an alternative biological fluid for therapeutic drug monitoring of mycophenolic acid in renal transplant recipients. arhfarm [Internet]. 2022 Oct. 16 [cited 2026 Jul. 12];72(Suppl. 4):S436-S437. Available from: https://asistent.ceon.rs/index.php/arhfarm/article/view/38398

Abstract

Mycophenolic acid (MPA) is widely used to prevent graft rejection in renal transplant recipients. For MPA therapeutic drug monitoring (TDM), saliva has been investigated as an alternative fluid to plasma. The main advantages of saliva are the non-invasive and cost-effective sample collection, permitting more frequent sampling. The purpose of this study was to examine the correlation between plasma and saliva MPA concentrations in renal transplant recipients and the potential of saliva for TDM of MPA. All patients (average age 44.33±11.45 years) were receiving 720-1440 mg/day of MPA (as enteric-coated mycophenolate sodium). Twenty-three paired blood and saliva samples were collected at pre-dose for MPA plasma and saliva trough concentration (C0) measurement. Both samples were centrifuged at 3000 rpm for 15 min and kept at -80°C until analysis. The MPA plasma C0 concentrations were determined by the validated high-performance liquid chromatography (HPLC) method. The liquid chromatography coupled to mass spectrometry (LC-MS) method was developed for determining MPA in saliva. Mean ± SD of MPA plasma C0 concentrations (5.24±2.19 µg/mL) in renal transplant recipients was about 100-fold higher than in saliva (55.53±24.75 ng/mL), which could be explained by the fact that the total fraction was analyzed in the plasma, and only the free fraction was assessed in saliva. The average salivary MPA C0 concentration correlated well with its plasma concentration (r=0.8474). Based on the good correlation between salivary and plasma MPA concentration, saliva can be considered as an alternative to plasma, particularly for unbound MPA monitoring in renal transplant recipients.

References

Ferreira PCL, Thiesen FV, de Araujo TT, D'Ávila DO, Gadonski G, de Oliveira CSA, et al. Comparison of plasma and oral fluid concentrations of mycophenolic acid and its glucuronide metabolite by LC-MS in kidney transplant patients. Eur J Clin Pharmacol 2019; 75(4): 553-9.

Džodić P, Veličković-Radovanović R, Šmelcerović A, Catić-Đorđević A, Stefanović N, Spasić A, et al. Validation of HPLC method for the determination of mycophenolic acid in human plasma obtained from renal transplant recipients. Acta Med Medianae 2016; 55(4): 28–36.

Autori koji objavljuju u ovom časopisu pristaju na sledeće uslove:

  1. Autori zadržavaju autorska prava i pružaju časopisu pravo prvog objavljivanja rada i licenciraju ga "Creative Commons Attribution licencom" koja omogućava drugima da dele rad, uz uslov navođenja autorstva i izvornog objavljivanja u ovom časopisu.

  2. Autori mogu izraditi zasebne, ugovorne aranžmane za neekskluzivnu distribuciju članka objavljenog u časopisu (npr. postavljanje u institucionalni repozitorijum ili objavljivanje u knjizi), uz navođenje da je članak izvorno objavljen u ovom časopisu.

  3. Autorima je dozvoljeno i podstiču se da postave objavljeni članak onlajn (npr. u institucionalni repozitorijum ili na svoju internet stranicu) pre ili tokom postupka prijave rukopisa, s obzirom da takav postupak može voditi produktivnoj razmeni ideja i ranijoj i većoj citiranosti objavljenog članka (Vidi Efekti otvorenog pristupa).